1. Home
  2. FNLC vs NPCE Comparison

FNLC vs NPCE Comparison

Compare FNLC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Bancorp Inc  (ME)

FNLC

First Bancorp Inc (ME)

N/A

Current Price

$36.49

Market Cap

415.5M

Sector

Finance

ML Signal

N/A

Logo Neuropace Inc.

NPCE

Neuropace Inc.

N/A

Current Price

$12.46

Market Cap

490.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNLC
NPCE
Founded
1864
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
415.5M
490.2M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
FNLC
NPCE
Price
$36.49
$12.46
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $20.00
AVG Volume (30 Days)
33.6K
★ 86.3K
Earning Date
10-21-2026
11-12-2026
Dividend Yield
★ 4.13%
N/A
EPS Growth
26.34
★ 29.03
EPS
★ 1.65
N/A
Revenue
N/A
★ $99,986,000.00
Revenue This Year
N/A
$0.36
Revenue Next Year
N/A
$22.05
P/E Ratio
$22.43
★ N/A
Revenue Growth
N/A
★ 25.13
52 Week Low
$24.63
$10.77
52 Week High
$37.50
$19.60

Technical Indicators

Market Signals
Indicator
FNLC
NPCE
Relative Strength Index (RSI) 68.52 41.89
Support Level $34.28 $12.46
Resistance Level N/A $15.26
Average True Range (ATR) 0.95 0.53
MACD 0.24 -0.00
Stochastic Oscillator 88.47 22.12

Price Performance

Historical Comparison
FNLC
NPCE

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: